Sulaeman Alzouabi @sarcoidosis

Sulaeman Alzouabi@sarcoidosis

Performance
0% Return
All

2024

2023

2022

2021

123.2%0%-123.2%

Return YTD 60.78%

Return 2Y -11.94%

Risk Score

Profitable Weeks 68.52%

Long-term multi-strategy. More in the bio.

Strategy: Multi-Strategy

The portfolio shows a diverse range of investments, indicating a balanced approach to managing risk.